---
document_datetime: 2023-09-21 21:11:33
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/elmiron-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: elmiron-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.0559226
conversion_datetime: 2025-12-27 15:53:18.621145
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## elmiron

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0027               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 15/07/2022                          |                                             | PL                               |           |
| IB/0026/G            | This was an application for a group of variations.                                               | 09/03/2022                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | manufacturing site for the FP - Secondary packaging site B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process   |            |            |                                  |                                                                                                                                                                                                                                                                       |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10614 /202106 | Periodic Safety Update EU Single assessment - pentosan polysulfate sodium (for centrally authorised product)                                                                                                                                                                                                                                                                                                                                                                                                                               | 13/01/2022 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                     |
| R/0024              | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 11/11/2021 | 11/01/2022 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of elmiron in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| N/0023              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                           | 21/07/2021 | 29/09/2021 | PL                               |                                                                                                                                                                                                                                                                       |
| IB/0022             | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                 | 04/05/2021 | n/a        |                                  |                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

| PSUSA/10614 /202006   | Periodic Safety Update EU Single assessment - pentosan polysulfate sodium (for centrally authorised product)                                                                                                                                                                                                                                        | 14/01/2021   | n/a        |             | PRAC Recommendation - maintenance                                                                                                          |
|-----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0021               | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                    | 10/12/2020   | n/a        |             |                                                                                                                                            |
| IB/0019               | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                      | 26/08/2020   | 29/09/2021 | SmPC and PL |                                                                                                                                            |
| N/0018                | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                    | 22/04/2020   | 29/09/2021 | PL          |                                                                                                                                            |
| PSUSA/10614 /201906   | Periodic Safety Update EU Single assessment - pentosan polysulfate sodium (for centrally authorised product)                                                                                                                                                                                                                                        | 30/01/2020   | 03/04/2020 |             | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10614/201906. |
| N/0017                | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                    | 26/02/2020   | 29/09/2021 | PL          |                                                                                                                                            |
| IB/0016/G             | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.2.e - Changes in the manufacturing process of | 27/09/2019   | n/a        |             |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|                     | ASMF B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure   |            |            |             |                                                                                                                                            |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| N/0014              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                      | 29/08/2019 | 03/04/2020 | PL          |                                                                                                                                            |
| PSUSA/10614 /201812 | Periodic Safety Update EU Single assessment - pentosan polysulfate sodium (for centrally authorised product)                                                                                                                                                                                                                                                                                                                          | 27/06/2019 | 23/08/2019 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10614/201812. |
| N/0013              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                      | 25/03/2019 | 23/08/2019 | PL          |                                                                                                                                            |
| IA/0011             | B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms                                                                                                                                                                                                                                                                                          | 15/02/2019 | n/a        |             |                                                                                                                                            |
| PSUSA/10614 /201806 | Periodic Safety Update EU Single assessment - pentosan polysulfate sodium (for centrally authorised product)                                                                                                                                                                                                                                                                                                                          | 17/01/2019 | n/a        |             | PRAC Recommendation - maintenance                                                                                                          |
| IB/0010             | B.II.f.1.b.2 - Stability of FP - Extension of the shelf                                                                                                                                                                                                                                                                                                                                                                               | 16/11/2018 | 31/01/2019 | SmPC,       |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|                     | life of the finished product - After first opening (supported by real time data)                                                                                                                    |            |            | Labelling and PL       |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IB/0008             | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 14/08/2018 | 31/01/2019 | SmPC, Labelling and PL |                                   |
| PSUSA/10614 /201712 | Periodic Safety Update EU Single assessment - pentosan polysulfate sodium (for centrally authorised product)                                                                                        | 14/06/2018 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0006             | B.II.f.z - Stability of FP - Other variation                                                                                                                                                        | 27/03/2018 | 31/01/2019 | SmPC and PL            |                                   |
| IA/0005             | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                        | 27/02/2018 | n/a        |                        |                                   |
| IB/0003             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                      | 05/02/2018 | 31/01/2019 | SmPC, Labelling and PL |                                   |
| N/0002              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                    | 23/10/2017 | 31/01/2019 | PL                     |                                   |
| N/0001              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                    | 30/08/2017 | 31/01/2019 | PL                     |                                   |